Skip to Main content Skip to Navigation
Master Thesis

L’évaluation de la qualité de vie a-t-elle sa place dans les essais cliniques en cancérologie ?

Abstract : The concept of quality of life in oncology is becoming more and more important whether it is with patients, health professionals but also with health authorities. This is due to the strong innovation that the field of cancerology has experienced in recent years. Among these innovations, we note the appearance of new targeted therapies, or new immunotherapies. These different treatments allow you to live longer with cancer. Quality of life then appears to be essential to take into account for patients. Health professionals are faced with a wider choice of therapies, the quality of life then makes it possible to differentiate certain treatments. From an economic point of view, quality of life if often measured to assess the cost-effectiveness of treatment compared to existing solutions on the market. This thesis highlights different current visions on the subject of quality of life. It allows us to analyze the place of quality of life in clinical trials today. It thus raises awareness of this concept by highlighting the problems that persist and by opening up many discussions that it seems very interesting to pursue.
Document type :
Master Thesis
Complete list of metadata
Contributor : Frédérique Gambade Connect in order to contact the contributor
Submitted on : Friday, March 5, 2021 - 2:35:14 PM
Last modification on : Thursday, April 15, 2021 - 3:11:41 AM
Long-term archiving on: : Sunday, June 6, 2021 - 7:00:27 PM


Files produced by the author(s)


  • HAL Id : dumas-03160731, version 1



Mathilde Lacombe. L’évaluation de la qualité de vie a-t-elle sa place dans les essais cliniques en cancérologie ?. Sciences du Vivant [q-bio]. 2020. ⟨dumas-03160731⟩



Record views